Interplay between inflammatory and estrogen signaling in breast cancer

Cytokine

Volumn 76, Issue 2, 2015, Pages 588-590

  Nagari, Anusha ^a   Franco, Hector L ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Estrogen receptor; FOXA1; Latent enhancer; TNF alpha (TNF )

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BINDING AFFINITY; BINDING SITE; BREAST CANCER; BREAST CARCINOGENESIS; DISEASE ACTIVITY; GENETIC ASSOCIATION; GENOME ANALYSIS; HUMAN; IMMUNE RESPONSE; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; BREAST TUMOR; FEMALE; INFLAMMATION; METABOLISM; PATHOLOGY;

BREAST NEOPLASMS; ESTROGENS; FEMALE; HUMANS; INFLAMMATION; SIGNAL TRANSDUCTION;

EID: 84943815209     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.06.012     Document Type: Article

References (10)

1. Baumgarten S.C., Frasor J. Minireview: inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers. Mol. Endocrinol. 2012, 26:360-371.
2. Ben-Neriah Y., Karin M. Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat. Immunol. 2011, 12:715-723.
3. Coussens L.M., Zitvogel L., Palucka A.K. Neutralizing tumor-promoting chronic inflammation: a magic bullet?. Science 2013, 339:286-291.
4. Franco H.L., Nagari A., Kraus W.L. TNF alpha signaling exposes latent estrogen receptor binding sites to alter the breast cancer cell transcriptome. Mol. Cell 2015, 58:21-34.
5. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
6. Hayden M.S., Ghosh S. Signaling to NF-kappaB. Genes. Dev. 2004, 18:2195-2224.
7. Hurtado A., Holmes K.A., Ross-Innes C.S., Schmidt D., Carroll J.S. FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat. Genet. 2011, 43:27-33.
8. Jozwik K.M., Carroll J.S. Pioneer factors in hormone-dependent cancers. Nat. Rev. Cancer 2012, 12:381-385.
9. Kalaitzidis D., Gilmore T.D. Transcription factor cross-talk: the estrogen receptor and NF-kappaB. Trends Endocrinol. Metab. 2005, 16:46-52.
10. Ostuni R., Piccolo V., Barozzi I., Polletti S., Termanini A., Bonifacio S., et al. Latent enhancers activated by stimulation in differentiated cells. Cell 2013, 152:157-171.